• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Only 8 Hospitals Have Attested for Meaningful Use Stage 2

by Jasmine Pennic 06/17/2014 1 Comment

Only 8 Hospitals Have Attested for Meaningful Use Stage 2

Only 8 hospitals have attested for meaningful use stage 2 out of a total of 75 hospitals during the 2014 reporting year, according to the latest data released by CMS. For physicians, only 447 eligible providers have attested for MU Stage 2 out of total 1,497.

Other key EHR Incentive program trends in the report include: 

  • Over 91% of eligible hospitals have received an EHR incentive payment for either MU or AIU
  • 88% of eligible professionals have registered for the Medicare or Medicaid EHR Incentive Programs
  • 68% of Medicare and Medicaid EPs have made a financial commitment to implementing an EHR
  • Over 380,000 Medicare and Medicaid EPs have received an EHR incentive payment

Meaningful Use Drop Out Rate

Last month, the American Medical Association (AMA) sent a letter to CMS and the ONC challenging the way the meaningful use EHR incentive program is being conducted. The letter stated that unless significant changes are made to MU program and future stages, it would increase the likelihood of:

• More physicians will drop-out of the MU Program;
• Patients will face disruptions and inefficiency in their care, as existing EHRs are unable to
migrate data or facilitate more coordinated care;
• Thousands of physicians will incur financial penalties that hinder future technology purchases
and limit resources dedicated to advancing care; and
• Outcomes-based delivery models, which require data driven approaches, will be jeopardized.

CMS data from 2013 revealed a 20% meaningful use drop out rate. To avoid an increase in the MU drop out rate. AMA recommends: 

  • Remove the existing program’s all-or-nothing approach and replace it with a 75 percent pass rate 
  • Allow physicians who meet at least 50 percent of the MU requirements to avoid a financial penalty
  • Remove the all-or-nothing approach and replace it with a 75 percent pass rate
  • The bar to avoiding a financial penalty should be lowered to 50 percent.
  • Remove the concept of menu vs. core
  • Streamline and refocus the number of requirements.
  • Remove any mandates that are outside the control of physicians.
  • Quality reporting programs must be aligned.
  • cost should be among the factors taken into consideration when requiring physicians to have to meet a particular MU mandate
  • MU mandates should be evidence-based

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |